NCT07023705View on ClinicalTrials.gov

MLPR As A Diagnostic Marker For Acute Pulmonary Embolism

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

May 31, 2025

Conditions
Pulmonary Embolism (Diagnosis)Diagnosis
Interventions
DIAGNOSTIC_TEST

Monocyte to Large Platelet Ratio (MLPR)

Admission laboratory values were used to calculate the Monocyte-to-Large Platelet Ratio (MLPR) by dividing the absolute monocyte count by the large platelet count. These values were obtained from blood samples collected before any treatment was administered.

Trial Locations (1)

Unknown

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT07023705 - MLPR As A Diagnostic Marker For Acute Pulmonary Embolism | Biotech Hunter | Biotech Hunter